Is SARS-CoV-2 an oncogenic virus?
A letter to the Journal of Infection looks at whether SARS-CoV-2 could be cancer causing.
Highlights:
-
Npa2 and Npa3 SARS-CoV-2 protein have the ability to hijack and degrade p53
-
Gene expression of p53 is downregulated in blood of COVID-19 patients.
-
Downregulation of p53 persists at least 24 weeks after infection in long COVID-19 patients
-
Long-term reduction of p53 could have impact on carcinogenesis.
Letter to the Journal of Infection